La Call 15 prevede la presentazione a due fasi di progetti su topic quali:
- Integrated research platforms enabling patient-centric drug development
- Blockchain enabled healthcare
- Microenvironment imposed signatures in tissue and liquid biopsies in immune-mediated diseases
- Emerging translational safety technologies and tools for interrogating human immuno-biology
- Development and validation of translational platforms in support of synaptopathy drug discovery
- Digital endpoints in neurodegenerative and immune-mediated diseases
La Call 16 prevede la presentazione a singola fase di proposte all’interno del programma AMR.
Le proposte devono essere presentate entro il 24 ottobre 2018.
Pewr maggiori informazioni va al link.
